Chondroitin sulfates (CS 4 and 6): Practical use and economical impact;Les chondroitines sulfates (CS 4 and 6): Schema d'utilisation et impact economique

Presse Medicale

Volumn 27, Issue 36, 1998, Pages 1866-1868

  Conrozier, Th ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANALGESIA; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; ECONOMIC ASPECT; FEMALE; FRANCE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRESCRIPTION; REVIEW; ARTICLE; COST BENEFIT ANALYSIS; DOSE RESPONSE; DRUG ADMINISTRATION; ECONOMICS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHONDROITIN SULFATES; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FRANCE; HUMANS; OSTEOARTHRITIS;

EID: 0032556546     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Blotman F, Loyau G. Clinical trial with chondroitin sulfate in gonarthrosis. Osteoarthritis Cartil 1993 ; 1:68 (Abst.).
2. Conrozier T, Vignon E. Effet du sulfate de chondroitine dans le traitement de l'arthrose de la hanche. Etude en double aveugle contre placebo. In : Le sulfate de chondroitine dans le traitement de l'arthrose. EULAR Ed., Bâle. Litera Rheumatol 1992 ; 14:69-75.
3. L'Hirondel JL. Etude clinique en double insu du sulfate de chondroïtine per os versus placebo dans la gonarthrose fémoro-tibiale (125 patients). Litera Rheumatol 1992 ; 14:77-84.
4. Uebelhart D, Chantraine A. Efficacité clinique du sulfate de chondroitine dans la gonarthrose:étude randomisée en double insu versus placebo. Rev Rhum 1994 ; 10:692.
5. Bourgeois P, Chales C, Dehais J, Delcambre B, Kuntz JL, Rozenberg S. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3×400/day vs placebo. Osteoarthritis Cartil 1998 ; 6 (suppl A): 25-30.
6. Buczi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow acting drug for osteoarthritis in the treatment of knee osteoarthritis. Osteoarthritis Cartil 1998 ; 6 (suppl A):31-6.
7. Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: Structure/disease modifying anti-osteoarthritic drug in the treatment of finger joint OA. Osteoarthritis Cartil 1998 ; 6 (suppl A):25-30.
8. Uebelhart D, Thonar EJ, Delmas PD, Chantraine A. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartil 1998 ; 6 (suppl A):39-46.
9. Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L. Comparison of the anti-inflammatory of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 1996 ; 23: 1385-91.